Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3

Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3

Background: Chemoresistance is a major obstacle to successful chemotherapy for human non-small cell lung cancer (NSCLC). Astragaloside IV, the component of Astragalus membranaceus, has been reported to exhibit anti-inflammation, anti-cancer and immunoregulatory properties. In the present study, we i...

Full description

Bibliographic Details
Main Authors: Cheng-Shi He, Yi-Cheng Liu, Zhi-Peng Xu, Peng-Chen Dai, Xiao-Wei Chen, De-Hai Jin
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-12-01
Series:Cellular Physiology and Biochemistry
Subjects:
Chemoresistance
Astragaloside IV
B7-H3
Non-small cell lung cancer
Online Access:http://www.karger.com/Article/FullText/453175

Internet

http://www.karger.com/Article/FullText/453175

Similar Items